Past Press

Cytovale Receives Additional $3.8M to Test Sepsis Diagnostic in SARS-CoV-2 Patients
April 23, 2020

Medical technology company Cytovale announced Thursday it has received an additional $3.8 million to fund a pilot study for its rapid sepsis diagnostic system for patients with respiratory infections....

Read More
Cytovale Receives Additional BARDA Funding to Evaluate Rapid Sepsis Diagnostic in Persons Under Investigation for COVID-19
April 23, 2020

US-based medical technology company Cytovale, Inc has expanded a partnership with the Biomedical Advanced Research and Development Authority (BARDA)...

Read More
Baton Rouge researchers look to sepsis for warnings
April 23, 2020

So far, O’Neal and his team have enrolled 280 patients in their pilot study, and most of them are suspected coronavirus patients. Researchers will use technology from a California-based company, Cytov...

Read More
See today's BioWorld MedTech Cytovale gets new BARDA funding to assess early sepsis detection technology for COVID-19
April 23, 2020

Cytovale Inc., a San Francisco-based medical technology company, has snagged an additional $3.83 million in funding from the U.S. Department of Health and Human Services’ Biomedical Advanced Research ...

Read More
Cytovale scoops up $15M to advance technology that aims to detect early sepsis
November 01, 2019

Cytovale Inc., a San Francisco-based medical technology company, has picked up $15 million in financing to advance its technology that enables the early detection of sepsis in the emergency department...

Read More
BARDA funds development of rapid sepsis test, digital diagnostic tool
October 31, 2019

The Biomedical Advanced Research and Development Authority (BARDA) announced that it will provide Cytovale of San Francisco an initial $3.4 million, with an option for an additional $4.17 million, to ...

Read More
Sepsis diagnostics: HHS to advance development of Cytovale rapid test
October 30, 2019

To advance the development of a test that may be able to diagnose sepsis in less than 10 minutes, the U.S. Department of Health and Human Services (HHS) will partner with Cytovale of San Francisco....

Read More
Medtech business Cytovale raised $7.4 million in an extension of its Series B
October 30, 2019

The funding is intended to support advancement of its tool for early detection of sepsis in the emergency department....

Read More
Cytovale Raises $15M in Funding
October 30, 2019

Cytovale, Inc., a San Francisco, Calif.-based medical technology company dedicated to innovating diagnostics using cell mechanics and machine learning, raised $15m in financing....

Read More
Cytovale Bags $15M for Sepsis-Detecting Tech
October 30, 2019

Cytovale today announced a $15 million financing for its sepsis-detecting technology for use in the emergency department....

Read More
Cytovale Receives $15M to Advance Sepsis Detection Tech
October 30, 2019

Cytovale announced today it has received a total of $15 million in financing to advance its technology for the early detection of sepsis in the emergency department....

Read More

Contact Us